Pacira Pharma (PCRX) Tops Q1 EPS by 22c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Pacira Pharma (PCRX) Tops Q1 EPS by 22c, Revenues Beat

Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update

May 7, 2020 8:01 AM EDT

-- Total revenues increased 16 percent over prior year first quarter --
-- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today reported financial results for the first quarter of 2020.

Prior to headwinds from the COVID-19 pandemic, which began in mid-March, we saw growing demand for EXPAREL continue with year-over-year growth rates of over 20 percent in January and February. Specifically, we saw demand continue to expand within... More